Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Glycopyrrolate: A Post Hoc Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled Studies

Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Glycopyrrolate: A Post Hoc Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled Studies

Edward M Kerwin,1 Lindsey Murray,2 Xiaoli Niu,3 Carole Dembek3 1Clinical Research Institute of Southern Oregon, Medford, OR, USA; 2Evidera, Bethesda, MD, USA; 3Sunovion Pharmaceuticals Inc., Marlborough, MA, USACorrespondence: Xiaoli NiuSunovion Pharmaceuticals Inc., 84 Waterford Dr, Marlborough, MA...

Full description

Bibliographic Details
Main Authors: Kerwin EM, Murray L, Niu X, Dembek C
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:International Journal of COPD
Subjects:
nebulized glycopyrrolate
clinically important deterioration
composite measure
Online Access:https://www.dovepress.com/clinically-important-deterioration-among-patients-with-chronic-obstruc-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/clinically-important-deterioration-among-patients-with-chronic-obstruc-peer-reviewed-article-COPD

Similar Items